Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Effect of Low Level Laser Therapy on Women With Obstructive Defecation Syndrome

13 agosto 2026 aggiornato da: Doaa A. Osman, Cairo University

Effect of Low Level Laser Therapy on Women With Obstructive Defecation Syndrome: A Randomized Controlled Trial

Obstructive defecation syndrome (ODS) is a condition in which a person has difficulty completely emptying the rectum during bowel movements. Women with ODS may experience excessive straining, a feeling of incomplete evacuation or blockage, abdominal discomfort, and the need to use manual assistance, laxatives, or enemas to facilitate defecation.

This randomized controlled trial will investigate the effect of adding low-level laser therapy (LLLT) to a conventional treatment program for women with ODS. Participants will be randomly assigned to one of two groups. The control group will receive nutritional modification and biofeedback training, while the study group will receive the same treatment in addition to low-level laser therapy applied to the lumbosacral region.

The study will evaluate whether adding low-level laser therapy can improve anorectal function, reduce the severity of ODS symptoms, and improve health-related quality of life compared with conventional treatment alone.

Panoramica dello studio

Descrizione dettagliata

This study is a prospective, randomized, pre-posttest controlled trial designed to investigate the effect of low-level laser therapy (LLLT) as an adjunct to conventional treatment in women with obstructive defecation syndrome (ODS).

Women diagnosed with ODS will be randomly assigned to two groups. Participants in the control group will receive nutritional modification and biofeedback training. Nutritional modification will focus on dietary fiber intake, adequate hydration, and weight-management recommendations. Biofeedback training will provide real-time feedback to facilitate appropriate pelvic floor muscle control, relaxation, and coordination during defecation.

Participants in the study group will receive the same nutritional modification and biofeedback program in addition to low-level laser therapy. LLLT will be applied to the lumbosacral region, targeting the lumbar (L2-L5) and sacral (S1-S5) areas.

Participants will be assessed before and after the intervention. Anorectal manometry will be used to evaluate anorectal physiological parameters, including anal resting pressure, squeeze pressure, strain pressure, endurance, rectal sensitivity, and rectal compliance. The severity of obstructive defecation symptoms will be evaluated using the Renzi Obstructive Defecation Syndrome Score, and health-related quality of life will be assessed using the Short Form-36 Health Survey (SF-36).

The study aims to determine whether adding low-level laser therapy to nutritional modification and biofeedback training provides additional benefits in anorectal function, ODS symptom severity, and quality of life compared with nutritional modification and biofeedback training alone.

Tipo di studio

Interventistico

Iscrizione (Stimato)

40

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Backup dei contatti dello studio

  • Nome: Radwa Ayad Mohamed, M.Sc

Luoghi di studio

      • Giza, Egitto
        • Faculty of Physical Therapy, Cairo University
        • Contatto:
        • Contatto:
          • Radwa Ayad Mohamed, M.Sc

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto

Accetta volontari sani

No

Descrizione

Inclusion Criteria:

  • Woman diagnosed with ODS according to the Renzi ODS score (≥ 9).
  • They suffer from difficult defecation for at least three months.
  • Their ages will range from 30-45 years old.
  • Their body mass index (BMI) will range from 25-30 kg/m2.
  • Their parity number will be 2-3 times.

Exclusion Criteria:

  • Any abnormalities around cancer colon, interstitial cystitis, or endometriosis.
  • Enlarged rectal diameter and damaged mienteric plexus and abnormal motor function of rectum.
  • Psychological or mental health problems.
  • Pregnancy and lactation
  • A history of previous pelvic surgery.
  • A history of retinopathy.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Comparatore attivo: Nutritional modification + Biofeedback muscle training
It will consist of 20 women with Obstructive Defecation Syndrome. They will be treated by nutritional modification and biofeedback muscle training, twice weekly for 8 weeks.
Participants will receive nutritional modification throughout the intervention period. The program will include a fiber-rich diet containing both soluble and insoluble fiber to improve stool consistency and facilitate bowel movements. Participants will also be instructed to maintain adequate hydration by consuming approximately 6-8 glasses of water per day. The nutritional modification program will be applied to participants in both the control and study groups.
Participants will receive anorectal biofeedback training using a rectal biofeedback device that provides real-time visual or auditory feedback on pelvic floor muscle activity. During each session, participants will be trained to improve pelvic floor muscle coordination and relaxation during simulated defecation. They will be instructed to consciously relax and release the pelvic floor muscles, use deep abdominal breathing, and practice relaxation techniques while observing the biofeedback signals. Exercises will be repeated approximately 10-20 times per session according to participant tolerance and therapist assessment. The intervention will be administered twice weekly.
Sperimentale: Low level laser therapy + Nutritional modification + Biofeedback muscle training
It will consist of 20 women with Obstructive Defecation Syndrome. They will be treated by the same nutritional modification and biofeedback muscle training, in addition to low level laser therapy, twice weekly for 8 weeks.
Participants will receive nutritional modification throughout the intervention period. The program will include a fiber-rich diet containing both soluble and insoluble fiber to improve stool consistency and facilitate bowel movements. Participants will also be instructed to maintain adequate hydration by consuming approximately 6-8 glasses of water per day. The nutritional modification program will be applied to participants in both the control and study groups.
Participants will receive anorectal biofeedback training using a rectal biofeedback device that provides real-time visual or auditory feedback on pelvic floor muscle activity. During each session, participants will be trained to improve pelvic floor muscle coordination and relaxation during simulated defecation. They will be instructed to consciously relax and release the pelvic floor muscles, use deep abdominal breathing, and practice relaxation techniques while observing the biofeedback signals. Exercises will be repeated approximately 10-20 times per session according to participant tolerance and therapist assessment. The intervention will be administered twice weekly.
Participants in the study group will receive low-level laser therapy (LLLT) using a Scanner Laser PR 999 4W device with dual wavelengths (continuous 808 nm and pulsed 940 nm). LLLT will be applied to the lumbosacral region, targeting the lumbar (L2-L5) and sacral (S1-S5) areas. Participants will be positioned prone, and the laser scanner will be applied perpendicular to the skin at a 90° angle, approximately 1-2 inches above the treatment area. The scanner will be moved slowly to provide uniform coverage of the lumbosacral region. Each treatment session will last 30 minutes and will be administered twice weekly for 8 weeks. Both participants and therapists will wear appropriate protective eyewear during treatment.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Obstructive Defecation Syndrome Severity Assessed by the Renzi ODS Score
Lasso di tempo: 8 weeks
The severity of obstructive defecation syndrome (ODS) will be assessed using the Renzi ODS Score. The scale consists of five items assessing excessive straining, incomplete rectal evacuation, use of enemas and/or laxatives, vaginal-anal-perineal digitations, and abdominal discomfort and/or pain. The total score ranges from 0 to 20, with higher scores indicating greater severity of ODS symptoms. A score of ≥9 is used to identify ODS.
8 weeks

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Anal Resting Pressure Assessed by Anorectal Manometry
Lasso di tempo: 8 weeks
Anal resting pressure will be assessed using anorectal manometry. After insertion of the anorectal manometry probe, the participant will be allowed to relax for approximately 3-5 minutes to allow anal sphincter tone to return to baseline. Basal anal pressure will then be recorded at rest over 60 seconds. The outcome will be expressed in mmHg.
8 weeks
Anal Squeeze Pressure Assessed by Anorectal Manometry
Lasso di tempo: 8 weeks
Anal squeeze pressure will be assessed using anorectal manometry during voluntary contraction of the anal sphincter and pelvic floor muscles. Participants will perform three maximum voluntary squeezes, each maintained for approximately 5 seconds, with a 30-second recovery period between attempts. The average pressure obtained from the three attempts will be used for analysis and expressed in mmHg.
8 weeks
Anal Strain Pressure Assessed by Anorectal Manometry
Lasso di tempo: 8 weeks
Anal strain pressure will be assessed using anorectal manometry during simulated defecation. Participants will be instructed to perform a bearing-down maneuver to simulate defecation. Three straining attempts will be performed, with each attempt lasting approximately 15 seconds and separated by a 30-second recovery interval. The average pressure obtained from the three attempts will be used for analysis and expressed in mmHg.
8 weeks
Anal Sphincter Endurance Assessed by Anorectal Manometry
Lasso di tempo: 8 weeks
Anal sphincter endurance will be assessed using anorectal manometry during a sustained maximum voluntary contraction. Endurance will be defined as the length of time for which the participant can maintain pressure during the maximum voluntary contraction. The outcome will be recorded in seconds, with a longer duration indicating greater ability to sustain the contraction.
8 weeks
Rectal Sensitivity Assessed by Anorectal Manometry
Lasso di tempo: 8 weeks
Rectal sensitivity will be assessed using graded balloon distension during anorectal manometry. Participants will be instructed to report the first rectal sensation, desire or urgency to defecate, and maximum tolerated sensation during progressive balloon inflation. The corresponding balloon volumes will be recorded in milliliters (mL). Lower sensory threshold volumes indicate greater rectal sensitivity, whereas higher threshold volumes indicate reduced rectal sensitivity.
8 weeks
Rectal Compliance Assessed by Anorectal Manometry
Lasso di tempo: 8 weeks
Rectal compliance will be assessed during anorectal manometry using controlled rectal balloon distension. Compliance will be determined from the relationship between changes in balloon volume and corresponding changes in steady-state intrarectal pressure (ΔV/ΔP). Higher values indicate greater rectal distensibility, whereas lower values indicate greater resistance to rectal distension.
8 weeks
Health-Related Quality of Life Assessed by the Short Form-36 Health Survey (SF-36)
Lasso di tempo: 8 weeks
Health-related quality of life will be assessed using the 36-item Short Form Health Survey (SF-36). The questionnaire evaluates eight health domains: physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to emotional problems, emotional well-being, social functioning, energy/fatigue, and general health perceptions. Each domain is scored from 0 to 100, with higher scores indicating a more favorable health status.
8 weeks

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Cattedra di studio: Mohamed Ahmed Mohamed Awad, PhD, Professor, Cairo University
  • Direttore dello studio: Doaa A. Osman, PhD, Ass. Professor, Cairo University
  • Direttore dello studio: Hesham Mahmoud Salah El-Din, PhD, Professor, Cairo University
  • Investigatore principale: Radwa Ayad Mohamed, M. Sc, PhD Student, Cairo University

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

20 agosto 2026

Completamento primario (Stimato)

20 dicembre 2026

Completamento dello studio (Stimato)

31 dicembre 2026

Date di iscrizione allo studio

Primo inviato

13 agosto 2026

Primo inviato che soddisfa i criteri di controllo qualità

13 agosto 2026

Primo Inserito (Effettivo)

18 agosto 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

18 agosto 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

13 agosto 2026

Ultimo verificato

1 agosto 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • P.T.REC/012/006002

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi